Idexx Laboratories Common Stock, Shares, Outstanding decreased by 0.6% to 79.2M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.9%, from 80.7M to 79.2M. Over 5 years (FY 2020 to FY 2025), Common Stock, Shares, Outstanding shows relatively stable performance with a -1.4% CAGR.
An increase suggests share issuance (dilution), while a decrease indicates share buybacks (accretion).
This is the total number of shares currently held by all shareholders, including institutional investors and company ins...
Standard metric for all public companies; essential for valuation and ownership analysis.
other_common_stock_shares_outstanding| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 85.1M | 84.9M | 84.6M | 84.2M | 83.4M | 83M | 82.9M | 83M | 83.1M | 83.1M | 83M | 82.9M | 82.5M | 82M | 81.6M | 80.7M | 80.2M | 80M | 79.7M | 79.2M |
| QoQ Change | — | -0.3% | -0.4% | -0.5% | -0.9% | -0.5% | -0.1% | +0.1% | +0.1% | +0.0% | -0.0% | -0.2% | -0.5% | -0.5% | -0.5% | -1.1% | -0.7% | -0.2% | -0.4% | -0.6% |
| YoY Change | — | — | — | — | -2.0% | -2.2% | -2.0% | -1.4% | -0.4% | +0.1% | +0.2% | -0.2% | -0.7% | -1.2% | -1.7% | -2.6% | -2.8% | -2.5% | -2.3% | -1.9% |